ERBB2 and neoplasm: In contrast, luminal B, HER2-E and TN are considered ‘aggressive’ subtypes, characterized by a tumor biology showing generally high grade, high mitotic/proliferation index, and a greater risk of local recurrence, metastasis and poor survival outcomes (19–21).